The Global Implantable Drug Eluting Device Industry is on the verge of a groundbreaking transformation, fueled by the latest forecast from Future Market Insights (FMI). Projections indicate a substantial Compound Annual Growth Rate (CAGR) of 6.0% from 2022 to 2029, catapulting the industry beyond the US$ 10 billion milestone by the close of this year. …